Sanford Guide Antimicrobial

66
Sanford Guide Antimicrobial is an Android app from Antimicrobial Therapy, Inc. in the Medical category, currently rated 4.8★ across 4,559 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 66: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 💎 In-app purchase plumbing | +$9K |
| ⚙ Medical complexity ×1.55 | +$32K |
| 🌐 Cross-platform reach (iOS + Android) | +$50K |
Synthetic estimate. Multiple band derived from iap / freemium model + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 💎 IAP / freemium model base | 28× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Medical category multiple | +12% |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Building · 61/100MID TIERcompetitive build-out- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.8★ across 4,559 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| subscriptionREVIEW | +$2,500 | |
| Excellent rating (4.8★)METRIC | +$2,200 | |
| worth every pennyREVIEW | +$2,000 | |
| excellent appREVIEW | +$1,500 | |
| Low install base (4,559 ratings)METRIC | +$1,500 | |
| Mature app (12y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Sanford Guide Antimicrobial
- Developer
- Antimicrobial Therapy, Inc.
- Bundle ID
- com.sanfordguide.amt
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.sanfordguide.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $517/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $4.99 - $79.99 per item
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
Features
Clinically Actionable, Concise Answers
Get exactly what you need to make the best decision in a fast-paced setting.
Institutionally Diverse Editorial Team by Design
Not every organization has the same patient population, budget, or processes. We bring perspectives from many medical institutions.
Constant Updates
New recommendations are added quickly by our nine-member editorial team.
‘Why Didn’t I Think of That’ Tools… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
More by Antimicrobial Therapy, Inc.
View all →Why medium confidence: 4,559 ratings · no founder-verified revenue (model estimate only).




